Millennium Management
VAXX

Millennium Management’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Millennium Management’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-48,194
Closed -$34.6K – 6758
2024
Q1 		$34.6K Buy
48,194
+5,306
+12% +$3.85K ﹤0.01% 5743
2023
Q4 		$36.5K Buy
+42,888
New +$41.4K ﹤0.01% 5527
2023
Q3 		– Sell
-14,012
Closed -$35.3K – 6712
2023
Q2 		$35.3K Sell
14,012
-227,175
-94% -$481K ﹤0.01% 5541
2023
Q1 		$547K Buy
241,187
+168,780
+233% +$428K ﹤0.01% 4544
2022
Q4 		$101K Buy
72,407
+56,244
+348% +$94.5K ﹤0.01% 5580
2022
Q3 		$32K Sell
16,163
-197,457
-92% -$411K ﹤0.01% 6330
2022
Q2 		$335K Buy
+213,620
New +$808K ﹤0.01% 5280
2022
Q1 		– Sell
-87,083
Closed -$489K – 7702
2021
Q4 		$489K Buy
+87,083
New +$900K ﹤0.01% 5065

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Millennium Management's VAXX Position: Q2 2024 in Review

Millennium Management sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 48,194 shares — an estimated $34.6K sold.

Millennium Management first reported a position in VAXX in Q4 2021 and held it in 8 quarters. The position peaked at $547K in Q1 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Millennium Management reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Millennium Management sold 48,194 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $34.6K.
  • Millennium Management first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2021 and held it in 8 quarters.
  • Millennium Management's Vaxxinity, Inc. Class A Common Stock position peaked at $547K in Q1 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.